Prednisone

Hematopoietic And Lymphoid Cell Neoplasm

M.D. Anderson Cancer CenterSmall moleculePhase 2Dormant

BB

66/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 53/ 100
Competitive Position: 89/ 100

Competitive context

115 Active assets in the Hematopoietic And Lymphoid Cell Neoplasm cohort.

Asset / Sponsor	Phase	Rating
Nivestim St. Jude Children's Research Hospital	Phase 2	BB
Pegloticase M.D. Anderson Cancer Center	Phase 4	BB
Rasburicase M.D. Anderson Cancer Center	Phase 4	BB
Cyclosporin A Children's Oncology Group	Phase 3	BB
Hydromorphon M.D. Anderson Cancer Center	Phase 4	BB

View all 50 →

Same molecule, other indications

Prednisone is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant

BBB

Indicative · Phase 3

74 / 100

diffuse large B-cell lymphomaActive

BBB

Indicative · Phase 4

74 / 100

peripheral T-cell lymphoma, not otherwise specifiedActive

BBB

Indicative · Phase 4

74 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.